- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-25-0002264

About Wexford Laboratories Private Limited
Data last updated:
Wexford Laboratories Private Limited is a private limited company based in Tumkur, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 August 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2002PTC030849. Its GSTIN is 29AAACW4383P4ZG (Karnataka). The company holds 6 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹72.15 Lakh. It is led by directors Bini Deepak and Deepak Badrinarayan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 18 KIADB Industrial Area Phase I Antharasanahalli, Tumkur, Karnataka, India – 572106.
As per the financials filed for FY 2024, the company reported a revenue of ₹83.63 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹87.78 Lakh (net margin 1%) and EBITDA of ₹4.94 Cr (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.
The company has about 164 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Wexford Laboratories. As per MCA filings, the company has open charges of ₹14.75 Cr and satisfied charges of ₹8.88 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 2 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in March 2019. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Inchem Laboratories Private Limited with revenue of ₹84.08 Cr.
Wexford Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-25-0002264). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wexfordindia.com.
Company details
Recognitions & Rankings of Wexford Laboratories
Contact details
Wexford Laboratories Private Limited's registered office is in Tumkur, Karnataka. Its website is wexfordindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 18 KIADB Industrial Area Phase I Antharasanahalli, Tumkur, Karnataka, India – 572106
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wexford Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Wexford Laboratories operates one associated brand: Wexford Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceuticals for overseas customers focusing on generics and branded products. | wexfordindia.com |
Business activity
The main business activity of Wexford Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Wexford Laboratories Private Limited, buy the company report.
Financials of Wexford Laboratories Private Limited
FY 2024 filings availableWexford Laboratories Private Limited reported revenue of ₹83.63 Cr (up 22% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 22% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.94 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹87.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wexford Laboratories Private Limited, buy the company report.
Board of directors of Wexford Laboratories Private Limited
Wexford Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bini Deepak | Director | 04 Nov 2002 | 24 Years 0 Months | Current |
| Deepak Badrinarayan | Director | 02 Aug 2002 | 24 Years 3 Months | Current |
Peer comparison
Wexford Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inchem Laboratories Private Limited | ₹84.08 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India | |||
| Macmillon Pharmaceuticals Private Limited | ₹83.91 Cr (FY 2024) | 50.0% | Punjab, India | |||
| Sunbeam Lifesciences Private Limited | ₹83.83 Cr (FY 2025) | 25.0% | Puducherry, India | |||
| Curetech Formulations Private Limited | ₹83.74 Cr (FY 2024) | 4.0% | Himachal Pradesh, India | |||
| Wexford Laboratories Private Limitedthis company | ₹83.63 Cr (FY 2024) | ₹87.78 Lakh | 1% | 22.0% | 164 | Tumkur, Karnataka, India |
| J Duncan Healthcare Private Limited | ₹82.47 Cr (FY 2025) | -57.0% | Shahapur, Maharashtra, India | |||
| Maxheal Pharmaceuticals (India) Limited | ₹82.41 Cr (FY 2024) | 10.0% | Mumbai, Maharashtra, India | |||
| Mepromax Life Sciences Private Limited | ₹82.29 Cr (FY 2025) | 2.0% | Wadhwan, Gujarat, India |
To see the full peer comparison of Wexford Laboratories Private Limited, buy the company report.
Auditor
Wexford Laboratories Private Limited is audited by Narayanan Patil and Ramesh for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Narayanan Patil and Ramesh | FY 2023 | 002395S |
Shareholding
The shareholding of Wexford Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wexford Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Sep 2017 | 100148497 | Others | ₹14.75 Cr | Open | |
| 05 Dec 2012 | 10392130 | Corporation Bank | ₹5.8 Lakh | Satisfied | |
| 26 Oct 2012 | 10392126 | Corporation Bank | ₹5.75 Lakh | Satisfied | |
| 02 Mar 2012 | 10341244 | Corporation Bank | ₹8 Lakh | Satisfied | |
| 22 Mar 2010 | 10216957 | Corporation Bank | ₹7.81 Cr | Satisfied |
To see the full charge records of Wexford Laboratories Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Wexford Laboratories Private Limited has 4 deals on record (4 secondary share transfers); the latest was in March 2019.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Wexford Laboratories Private Limited has 7 court cases on record: 2 filed by Wexford Laboratories, 5 filed against it. 2 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
| High courts | 3 | 2 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0104-Labour Matters : Matters relating to wages, bonus, ad-hoc, casual daily wages & their regularisation) | Filed by the company against North Karnataka Durgs and Pharmaceutical Manufacturers Welfare Association Represented by Its Hon.Secretary C/O Nandu Chemicals Pvt.Ltd., N-12, Industrial Estate Gokul Road Hubli-580 030 , , Karnataka and 19 others | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against an individual | Pending |
| District court, TUMAKURU, Karnataka | Court case (Appl.10(4)(A)) | Filed against the company by an individual | Pending |
| District court, TUMAKURU, Karnataka | Court case (Appl.10(4)(A)) | Filed against the company by an individual | Disposed |
| District court, TUMAKURU, Karnataka | Court case (IDact of S10) | Filed against the company by individuals | Disposed |
To see the full case history of Wexford Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wexford Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Wexford Laboratories Private Limited has a workforce of 164 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 164 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Wexford Laboratories Private Limited, buy the company report.
GST
Wexford Laboratories has 6 GST registrations: 2 active and 4 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACW4383P4ZG | Karnataka | Active | 01 Jul 2017 |
| 24AAACW4383P1ZT | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Wexford Laboratories Private Limited, buy the company report.
Recent activity
Wexford Laboratories Private Limited has 2 board changes on record since 2002: 2 appointments. The latest: Bini Deepak was appointed as Director on 04 Nov 2002.
7 earlier events are in the company report.
Frequently asked questions
Wexford Laboratories is an active private limited company based in Tumkur, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 August 2002 (24+ years old) and is registered under CIN U24231KA2002PTC030849.
Wexford Laboratories has 2 current directors:
- Bini Deepak - Director
- Deepak Badrinarayan - Director
The latest financial statements of Wexford Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Wexford Laboratories is 29AAACW4383P4ZG, registered in Karnataka. The company has 6 GST registrations in all, of which 2 are active and 4 are cancelled or inactive. Other active GSTINs include 24AAACW4383P1ZT (Gujarat).
The CIN (Corporate Identification Number) of Wexford Laboratories is U24231KA2002PTC030849. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wexford Laboratories has 7 court cases on record: 2 filed by the company and 5 filed against it. 2 are pending. Most are in the district courts.
Wexford Laboratories was incorporated on 02 August 2002, making it 24+ years old. It is registered with the Registrar of Companies, Bangalore.
Wexford Laboratories has 4 deals on record (4 secondary share transfers); the latest was in March 2019.
The peers of Wexford Laboratories by revenue are Inchem Laboratories Private Limited, Macmillon Pharmaceuticals Private Limited, Sunbeam Lifesciences Private Limited, Curetech Formulations Private Limited, J Duncan Healthcare Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bini Deepak was appointed as Director on 04 Nov 2002. Deepak Badrinarayan was appointed as Director on 02 Aug 2002.
Yes, Wexford Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-25-0002264).

